Hilakivi I, Mäkelä J, Leppävuori A, Putkonen P T
Med Biol. 1978 Jun;56(3):138-43.
Sixteen hour polygraphic recordings (EEG, EOG and EMG) were obtained from 14 adult cats after intraperitoneal injections of propranolol (5 mg/kg) or pindolol (0.1 or 0.5 mg/kg). All injections moderately increased waking, which consisted mainly of a sedated drowsy stage. Both drugs also decreased deep slow wave sleep, while light slow wave sleep remained at control levels. The changes were more marked after propranolol, which also significantly reduced paradoxical sleep (PS). The decrease in the deeper stages of sleep and PS is suggested as being due to blockade of the central adrenergic beta-receptors per se and/or antagonistic effects of the beta-blockers on 5-HT receptors. The results agree with the finding that beta-blockers cause insomnia in susceptible patients, but they do not suggest that intensified dreaming or nightmares reported by others are likely to be caused by increased PS.
对14只成年猫腹腔注射普萘洛尔(5毫克/千克)或吲哚洛尔(0.1或0.5毫克/千克)后,进行了16小时的多导睡眠图记录(脑电图、眼电图和肌电图)。所有注射均适度增加了清醒时间,主要表现为镇静性嗜睡阶段。两种药物还减少了深度慢波睡眠,而浅度慢波睡眠维持在对照水平。普萘洛尔后的变化更为明显,它还显著减少了快速眼动睡眠(PS)。睡眠较深阶段和快速眼动睡眠的减少被认为是由于中枢肾上腺素能β受体本身被阻断和/或β受体阻滞剂对5-羟色胺受体的拮抗作用。这些结果与β受体阻滞剂在易感患者中导致失眠的发现一致,但并未表明其他人报告的强化梦境或噩梦可能是由快速眼动睡眠增加引起的。